An effect of therapy with small doses of omega-3 polyunsaturated acids on renal reserve and metabolic disturbances in patients with primary IgA glomerulopathy;Wpływ leczenia małymi dawkami wielonienasyconych kwasów tłuszczowych typu omega-3 na rezerwȩ nerkowa̧ i zaburzenia metaboliczne u pacjentów z pierwotnymi kłȩbuszkowymi zapaleniami nerek typu nefropatii IgA

Polskie Archiwum Medycyny Wewnetrznej

Volumn 108, Issue 2, 2002, Pages 753-760

  Sulikowska, Beata ^a   Manitius, Jacek ^a   Niewȩgłowski, Tomasz ^a   Szydłowska Łysiak, Wiesława ^b   Rutkowski, Bolesław ^a  

^a Klinika Nefrologii   (Poland)

^b Zakład Zywienia K ^*

Author keywords

Cholesterol; IgA glomerulopathy; Insulin; Omega 3 polyunsaturated fatty acids; Renal reserve

Indexed keywords

DOCOSAHEXAENOIC ACID; DOPAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; URIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CREATININE CLEARANCE; FEMALE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INSULINEMIA; MALE; METABOLIC DISORDER; PROTEINURIA; STATISTICAL SIGNIFICANCE;

EID: 0036039888     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Anderson E.A., Hoffman R.P. i wsp.: Hyperinsulinemia produces both symphatetic neural activation and vasodilatation in normal humans. J. Clin. Invest., 1991, 87, 2246.
2. Berger J.: IgA glomerular deposits in renal disease. Transplant. Proc., 1969, 1, 939.
3. Blok W.L., Katon M.B. i wsp.: Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J. Nutr. 1996, 126(6), 1515.
4. Brongeest-Schonte H.C., Gent C.M. i wsp.: The effect of intakes of omega-3 fatty acids on the blood lipid composition in healthy human subject. Am. J. Clin. Nutr., 1981, 34, 1752.
5. Budzyńska-Topołowska J., Ziemiański S. i wsp.: RoIa wielonienasyconych kwasów z rodziny n-3 w zapobieganiu i leczeniu miażdżycy. Czynniki Ryzyka, 1994, 2, 55.
6. Cartwright J., Pockley A.G. i wsp.: The effect of dietary omega-3 acids on erythrocyte membrane phospholipids and blood viscosity in healthy volunteers. Artherosclerosis, 1985, 55, 267.
7. Caterina R., Caprioli R. i wsp.: n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int., 1993, 44, 843.
8. Caterina R., Endres S. i wsp.: n-3 fatty acids and renal diseases. Am. J. Kidney Dis., 1994, 24(3), 397.
9. Cheng I.K.P., Chon P.C.K. i wsp.: The effect of fish oils dietary supplementation on the progresion of mesangial IgA glomerulonephritis. Nephrol Dial. Transplant. 1990, 5: 241-6.
10. D'Amico G., Ragni A. i wsp.: Typical and atypical natural history of IgA nephritis in adult patients. Contrib. Nephrol., 1994, 104, 6.
11. Donadio J., Bergstralh E. i wsp.: A controlled trial of fish oil in IgA nephropathy. N. Engl. J. Med., 1994, 331, 1194.
12. Donadio J., Grande J. i wsp.: The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Am. J. Soc. Nephrol., 1999, 10, 1772.
13. Fox J., Manitius J., Rutkowski B. i wsp.: Wpływ podawania kwasów omega-3 na zachowanie siȩ lipidów w surowicy knvi, stan czynnościowy błony erytrocyta oraz funkcjȩ nerek u pacjentów z pierwotnymi kłȩbuszkowymi zapaleniami nerek,. Przegl. LeL, 1996, 53(12), 858.
14. Gentile M.B., Felin G. i wsp.: Treatment of proteinuric patients with a vegetarian soy diet and fish oils. Clin. Nephrology, 1993, 40(6), 315.
15. Hugson M. i wsp.: Mesangial proliferative glomerulonephritis in Sauth-Western Amerixcan Indians. Am. J. Kidney Dis., 1993, 21, 486.
16. Ibels L.S., Gyory A.Z. i wsp.: IgA nephropathy: Analysis of the natural history, important factors in the progression of renal disease and review of the literature. Medicine (Baltimore) 1994, 73, 79.
17. Johnson R., Klvlinhs S. i wsp.: Reappraisal of the pathogenesis and conseqences of hyperuricemia in hypertension, cardiovascular disease and renal disease. Am. J. Kidney Dis., 1999, 33, 225.
18. Keane W.F.: Lipids and the kidney. Kidney Int., 1994, 46, 910.
19. Kirmani Z.A., Baxter C.R. i wsp.: Effect of omega-3 fatty acids on the relative blood viscosity and platelet. J. Burn. Care Rehabil., 1995, 16, 306.
20. Levy M., Beaufils H. i wsp.: Idiopathic recurrent macroscopic hematuria and mesangial IgA-IgG deposits in children. Clin. Nephrol., 1973, 1, 63.
21. Machiguchi T., Yosihida H. i wsp.: Does circulatory erythropoietin reflect progression of IgA neprhopathy. Comparison with urinary NAG: Nephrol. Dial. Transplant., 1999, 14, 635.
22. Małyszko J., Małyszko J. i wsp.: Wpływ leczenia kłȩbuszkowych zapaleń nerek kwasami tłuszczowymi omega-3 na wybrane parametry układu homeostazy, funkcjȩ płytek oraz gospodarkȩ lipidowa̧. Przegl. Lek., 1996, 53(8), 600.
23. Maintins J.: The effect of renal metabolism on renal function. Ann. Acad. Med. Gedan., 1995, 25(6).
24. Manitius J., Rutkowski B.: Nefropatia nadciśnieniowa. [w:] Krupa-Wojciechowska B., Rutkowski B. Nadciśnienie tȩtnicze w codziennej praktyce. Wyd. Medyczne MAKmed Gdańsk, 1997.
25. Manitius J., Sulikowska B., Rutkowski B. i wsp.: The effect of dietary enrichment with fish oil on urinary excretion of N-acetyl-beta-D glucosainidase and renal function in proteinuric patients with primary glomerulopathies. Int. Urol. Nephrol., 1997, 29, 67.
26. Nalin L., Caerteati M.: Management of IgA nephropathy: Evidence based recommendations. Kidney Int., 1999, 55 (suppl. 70): 56.
27. Nickelet V., Mihetsch M.J.: Uric acid nephropathy and end-stage disease - review of a disease. Nephrol. Dial. Transplant., 1997, 12, 1832.
28. Petterson E.E., Rekola S. i wsp.: Treatment of IgA nephropathy with Omega-3 polyunsaturated fatty acids: a prospective, double-blind, randomized study. Clin. Nephrology, 1994, 94(4), 183.
29. Reaven G.M.: The kidney: An unwicking accomplice in Syndrom X. Am. J. Kidney Dis. 1997, 30, 928.
30. Sakai H., Abek D. i wsp.: Clinical guidelines of IgA nephropathy. Jpn. J. Nephrol., 1995, 37, 417.
31. Staut R.W.: Insulin as a mitogenic factor: role in pathogenesis of cardiovascular disease. Am. J. Med., 1991, 90, 62.
32. Syrjanen J., Mustonen J. i wsp.: Hypertriglicerydemia and hyperuricemia are the risk factors for progression of IgA nephropathy. Nephrol. Dial. Transplant., 2000, 15, 34.
33. Wachtler P., Konig W. i wsp.: Influence of a total parenteral nutrition enriched with omega-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J. Trauma, 1997, 42, 191.